ENDRA Life Sciences Inc - Warrants (12/05/2022)
NDRAW
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.76M
Close$
Share Statistics
| Market cap | $3.76 Million |
|---|---|
| Enterprise Value | $3.86 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.93 |
| Beta | 4.23 |
| Outstanding Shares | 1,199,586 |
Return
| Return on Equity | -408.67% |
|---|---|
| Return on Assets | -212.39% |
| Return on Invested Capital | -61.32% |
Valuation & Multiples
| P/E Ratio | -0.61 |
|---|---|
| PEG | -2.3 |
| Price to Sales | - |
| Price to Book Ratio | 0.03 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ENDRA Life Sciences Inc
18 employees